Form 4: Precigen Director Jeffrey B. Kindler Reports Stock Transaction
SEC Form 4 Filing
Director Jeffrey B. Kindler reported a transaction involving Precigen, Inc. common stock and restricted stock units on March 9, 2024.
Summary
- On March 9, 2024, Jeffrey B. Kindler, a director of Precigen, Inc., engaged in a transaction involving the company's securities.
- The transaction involved the vesting of 106,837 restricted stock units (RSUs) which converted into common stock.
- Following the transaction, Kindler directly owns 345,112 shares of Precigen common stock.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing, so the sentiment is neutral.
Industry Context
This filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their transactions in the company's stock.
Stakeholder Impact
- The transaction provides transparency to shareholders regarding insider activity.
Key Dates
| Date | Description |
|---|---|
| 03/09/2024 | Date of transaction involving vesting of restricted stock units and conversion to common stock. |
| 03/12/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.